UT Health San Antonio, Ohio Company Reach License Agreement To Develop Chlamydia Vaccine
December 14, 2022
December 14, 2022
SAN ANTONIO, Texas, Dec. 14 (TNSres) -- The University of Texas Health Science Center at San Antonio issued the following news release:
The University of Texas Health Science Center at San Antonio has granted an exclusive global license allowing an Ohio biopharmaceutical company to develop university research discoveries into a novel oral vaccine for chlamydia.
According to the U.S. Centers for Disease Control and Prevention (CDC), chlamydia is the bacterial sexually tr . . .
The University of Texas Health Science Center at San Antonio has granted an exclusive global license allowing an Ohio biopharmaceutical company to develop university research discoveries into a novel oral vaccine for chlamydia.
According to the U.S. Centers for Disease Control and Prevention (CDC), chlamydia is the bacterial sexually tr . . .